Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.5549
Delayed Data
As of Sep 29
 -0.0182 / -3.18%
Today’s Change
0.32
Today|||52-Week Range
6.90
-82.66%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close0.57
Today’s open0.59
Day’s range0.55 - 0.60
Volume1,094,234
Average volume (3 months)1,768,995
Market cap$65.2M
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+35.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+19.60%
P/E ratioNM
Price/Sales143.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.06-5.17%
NTECIntec Pharma Ltd+0.11+1.94%
MBRXMoleculin Biotech In...+0.21+3.66%
CRMECardiome Pharma Corp-0.06-1.90%
Data as of 3:59pm ET, 09/29/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.7M
Annual profit (last year)-$114.7M
Net profit margin-6,598.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer &
Secretary
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

Search for Jobs